Thanks so much Brian. This is wonderful to be able to read: that ICT-107, in his opinion, is the best designed immunotherapy product today! I am not surprised and glad that Manish stands behind the science!
Yes, I found it. Thank you, Brian. Can you tell us whether the "operational and administrative issues" that caused the separation had anything to do with a buy out or partnership earlier than the BOD may have wanted?
Given the apparent initial differences of opinion regarding his entitlement to severance compensation I would have been more than surprised if his attorney had allowed him to comment publicly prior to an agreement being reached in that regard.